{ "cik": 1359931, "cik_padded": "0001359931", "entityName": "Protara Therapeutics, Inc.", "fiscal_years": [ { "accn": "0001213900-26-025433", "filed": "2026-03-10", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 94000.0, "cash": 49657000.0, "eps_diluted": -1.34, "free_cash_flow": -56459000.0, "net_income": -57439000.0, "operating_cash_flow": -56365000.0, "operating_income": -64549000.0, "stockholders_equity": 196412000.0, "total_assets": 209468000.0, "total_liabilities": 13056000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06647251695415758, "roa_avg2y": -0.29386424913409837, "roa_period_end": -0.2742137223824164, "roe_avg2y": -0.31599302426653025, "roe_period_end": -0.29244139869254426 } }, { "accn": "0001213900-26-025433", "filed": "2026-03-10", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 63000.0, "cash": 162798000.0, "eps_diluted": -2.17, "free_cash_flow": -35871000.0, "net_income": -44596000.0, "operating_cash_flow": -35808000.0, "operating_income": -49154000.0, "stockholders_equity": 167134000.0, "total_assets": 181454000.0, "total_liabilities": 14320000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08567975396986849, "roa_avg2y": -0.3425086786888268, "roa_period_end": -0.24577027786656674, "roe_avg2y": -0.37880699072009516, "roe_period_end": -0.2668278148072804 } }, { "accn": "0001213900-26-025433", "filed": "2026-03-10", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 45000.0, "cash": 39586000.0, "eps_diluted": -3.57, "free_cash_flow": -37602000.0, "net_income": -40420000.0, "operating_cash_flow": -37557000.0, "operating_income": -43613000.0, "stockholders_equity": 68321000.0, "total_assets": 78954000.0, "total_liabilities": 10633000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1556329679015237, "roa_avg2y": -0.4205072720084892, "roa_period_end": -0.5119436633989412, "roe_avg2y": -0.4744020093425037, "roe_period_end": -0.591618975132097 } }, { "accn": "0001213900-25-020368", "filed": "2025-03-05", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 120000.0, "cash": 24127000.0, "eps_diluted": -5.86, "free_cash_flow": -26577000.0, "net_income": -65952000.0, "operating_cash_flow": -26457000.0, "operating_income": -67062000.0, "stockholders_equity": 102083000.0, "total_assets": 113290000.0, "total_liabilities": 11207000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10978321561866325, "roa_avg2y": -0.46138670658933983, "roa_period_end": -0.5821519992938476, "roe_avg2y": -0.49964204138683393, "roe_period_end": -0.64606251775516 } }, { "accn": "0001213900-24-021982", "filed": "2024-03-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 596000.0, "cash": 35724000.0, "eps_diluted": -4.21, "free_cash_flow": -35098000.0, "net_income": -47252000.0, "operating_cash_flow": -34502000.0, "operating_income": -47489000.0, "stockholders_equity": 161914000.0, "total_assets": 172596000.0, "total_liabilities": 10682000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06597329446496288, "roa_avg2y": -0.25150564333485026, "roa_period_end": -0.27377227745718324, "roe_avg2y": -0.2616701323801006, "roe_period_end": -0.2918339365342095 } }, { "accn": "0001213900-23-018373", "filed": "2023-03-08", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 884000.0, "cash": 168598000.0, "free_cash_flow": -24291000.0, "net_income": -33978000.0, "operating_cash_flow": -23407000.0, "operating_income": -34444000.0, "stockholders_equity": 199243000.0, "total_assets": 203157000.0, "total_liabilities": 3914000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.019644353879433658, "roa_avg2y": -0.3324982875036696, "roa_period_end": -0.16724995939101286, "roe_avg2y": -0.3447530629328057, "roe_period_end": -0.17053547677961084 } }, { "accn": "0001213900-22-011208", "filed": "2022-03-09", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 475000.0, "cash": 564000.0, "free_cash_flow": -5486000.0, "net_income": -7830000.0, "operating_cash_flow": -5011000.0, "operating_income": -7830000.0, "stockholders_equity": -2128000.0, "total_assets": 1223000.0, "total_liabilities": 3351000.0 }, "period_end": "2019-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -0.6328806983511154, "roe_avg2y": -5.909433962264151 } }, { "accn": "0001213900-21-014709", "filed": "2021-03-11", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 119000.0, "cash": 19371000.0, "free_cash_flow": -23352000.0, "net_income": -20729000.0, "operating_cash_flow": -23233000.0, "operating_income": -21372000.0, "stockholders_equity": 4778000.0, "total_assets": 23521000.0, "total_liabilities": 3078000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.644202595228129, "roa_avg2y": -0.6141925925925926, "roa_period_end": -0.8812975638790868, "roe_avg2y": -1.049091553216256, "roe_period_end": -4.338426119715362 } }, { "accn": "0001171843-20-001860", "filed": "2020-03-20", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 35000.0, "cash": 21170000.0, "free_cash_flow": -22387000.0, "net_income": -29964000.0, "operating_cash_flow": -22352000.0, "operating_income": -30362000.0, "stockholders_equity": 34740000.0, "total_assets": 43979000.0, "total_liabilities": 9240000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2659758203799655, "roa_avg2y": -0.684899255991497, "roa_period_end": -0.6813251779258284, "roe_avg2y": -0.8189010808816496, "roe_period_end": -0.8625215889464593 } }, { "accn": "0001171843-19-001687", "filed": "2019-03-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 271000.0, "cash": 36392000.0, "free_cash_flow": -23958000.0, "net_income": -28526000.0, "operating_cash_flow": -23687000.0, "operating_income": -28705000.0, "stockholders_equity": 38441000.0, "total_assets": 43520000.0, "total_liabilities": 5079000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.13212455451210947, "roa_period_end": -0.65546875, "roe_period_end": -0.7420722665903593 } } ], "latest_filing": { "accn": "0001213900-26-025433", "filed": "2026-03-10", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001359931.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001359931.json" }, "ticker": "TARA" }